Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist's Medication Review Recommendation

Los Angeles, California Survey Completed on 05-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to act in a timely manner on the consultant pharmacist's recommendation regarding a resident's medication regimen. Specifically, a resident with diagnoses including psychosis, bipolar disorder, and diabetes mellitus was started on Olanzapine for psychosis manifested by constant worrying about a medical condition. The consultant pharmacist reviewed the medication regimen and recommended that the physician clarify and update the order for Olanzapine with appropriate behavioral indications. However, there was no documentation that the nursing staff followed up with the physician to address this recommendation or to clarify the behavioral manifestations justifying the use of the psychotropic medication. The resident's clinical records did not show any action taken by the licensed nursing staff to discuss or implement the pharmacist's recommendation, despite the psychiatrist evaluating the resident shortly after the recommendation was made. The facility's policy required that recommendations from the consultant pharmacist be acted upon and documented by staff or the prescriber, but this was not done. As a result, the resident was at risk for receiving unnecessary medication due to the lack of timely follow-up and documentation.

An unhandled error has occurred. Reload 🗙